FDA Approved: VOSEVI — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

VOSEVI (sofosbuvir/velpatasvir/voxilaprevir) is approved as an oral, fixed-dose combination for treatment of chronic hepatitis C virus infection in adults who h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• VOSEVI (sofosbuvir/velpatasvir/voxilaprevir)

Snippet

ORIG AP for VOSEVI (SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR)